ENTITY

Shenzhen Chipscreen Bioscience (688321 CH)

24

Analysis

Health Care • China

Shenzhen Chipscreen Biosciences Co., Ltd. operates as a drug development company. The Company produces and sells anticancer drugs, immunological disease therapeutic drugs, metabolic disease therapeutic drugs, and other products. Shenzhen Chipscreen Biosciences markets its products throughout China.

more

Refresh

Exchange Announcement • 06 Apr 2021 17:22

Announcement on the shareholding status of the top ten shareholders and the top ten shareholders of unrestricted shares on the issue of share repurchase (关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告)

Exchange Announcement • 18 Mar 2021 18:19

Independent opinions of independent directors on matters related to the first meeting of the second board of directors (独立董事关于第二届董事会第一次会议相关事项的独立意见)

Exchange Announcement • 17 Mar 2021 17:45

Voluntary disclosure of announcements on obtaining clinical trial notifications (自愿披露关于获得临床试验通知书的公告)

Exchange Announcement • 16 Mar 2021 18:33

Voluntary Disclosure Announcement on the inclusion of the company's products in the proposed breakthrough treatment varieties (自愿披露关于公司产品纳入拟突破性治疗品种公示的公告)

Exchange Announcement • 10 Mar 2021 17:18

Meeting Materials Of The First Extraordinary General Meeting Of Shareholders In 2021 (2021年第一次临时股东大会会议资料)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x